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We have studied the presence of high-mobility-group (HMG) chromatin proteins in undifferentiated F9 mouse teratocar- 
cinema cells and F9 cells, which were induced to differentiate by treatment with retinoic acid and dibutyryl-CAMP for 
5 days, Acetic acid/urea-polyacrylamide gel electrophoresis and reversed-phase HPLC revealed that the induced F9 cells 
contained 77 and 62% less HMG I and HMG Y, respectively, than their untreated counterparts. The relative amounts 
of two other low-M, HMG proteins HMG 14 and HMG 17 remained essentially unchanged and only a minor decrease 
was observed in the content of one of the high-M, HMG proteins, HMG 2. The identity of the low-M, HMG proteins 
was verified by amino acid analysis or partial sequencing. These results suggest that HMG I and HMG Y are HMG 
proteins specific for undifferentiated cells. 
High-mobility-group protein; Cell differentiation: Chromatin; (Mouse teratocarcinoma cell) 
1. INTRODUCTION 
High-mobility-group proteins constitute a 
subclass of non-histone chromatin proteins of 
general occurrence in all four eukaryotic kingdoms 
[ 11. The high-M1 HMG proteins HMG 1 and HMG 
2 bind to single-stranded DNA and may affect the 
superhelicity of DNA [2,3]. The low-M, HMG pro- 
teins HMG 14 and HMG 17 bind to DNA in 
nucleosomal core particles on the inner side of the 
DNA [4]. These proteins have been implicated in 
modifying the chromatin structure of transcrip- 
tionally active genes [5]. In addition to these well- 
characterized HMG proteins, two new low-M, 
HMG proteins HMG I and HMG Y have been 
recently found from proliferating cells [6]. 
Mouse teratocarcinoma cell line F9 can be in- 
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duced to differentiate to a cell type characteristic 
of parietal endoderm when treated with retinoic 
acid and dibutyryl-CAMP [7,8]. Since the available 
data suggest that HMG proteins are important 
structural elements of chromatin, we have studied 
the presence of these proteins in undifferentiated 
and differentiated F9 cells to elucidate further their 
role in the differentiation process. 
2. MATERIALS AND METHODS 
2.1. Cell culture 
F9 teratocarcinoma cells were obtained from Dr Dorothe 
Spillman (Biocenter, University of Basel). The cell line was 
cultivated in Dulbecco’s modified Eagle’s medium sup- 
plemented with 10% fetal calf serum, 2 mM glutamine, 100 
U/ml penicillin and 0.1 mg/ml of streptomycin (Gibco, 
Scotland) in a humidified 90% air/IO% CO* incubator. The 
cells were induced by treating the cultures first with 0.5 x 10m6 
M retinoic acid (Sigma) for 72 h, followed by a wash and then 
with 1 x lo-’ M dibutyryl-CAMP (Sigma) for 48 h according 
to [7] and collected. The morphology of the cells became clearly 
more rounded after 24 h in the presence of dibutyryl-CAMP. 
Untreated cells were collected from cultures grown for 5 days 
to confluency. 
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2.2. Extraction of HMG proteins 
HMG proteins and histone Hl were extracted from whole 
cells with 5% perchloric acid (PCA) at 0°C [9]. Proteins were 
precipitated by adding 100% trichloroacetic acid to a final con- 
centration of 25% (w/v) and incubated at 0°C for 2 h before 
centrifuging for 40 min at 10000 x g. The precipitate was 
washed once with acetone/cone. HCl (400:1), once with 
acetone/O. 1 M HCl (6: 1), twice with acetone, and lyophilized. 
2.3. Polyacrylamide gel electrophoresis 
Electrophoresis was performed according to Panyim and 
Chalkley [lo] using 15% polyacrylamide slab gels in acetic 
acid/2.5 M urea. Proteins treated with alkaline phosphatase [6] 
were analyzed using a discontinuous system described by Spiker 
[ll]. Coomassie-stained proteins were analyzed by den- 
sitometry as in [12]. 
2.4. Reversed-phase HPLC 
A Hewlett-Packard 1090 liquid chromatograph was used. 
The low-M, HMG proteins were resolved on a Bio-Rad RP-304 
(C4) column (250 x 4.6 mm) and the proteolytic fragments of 
HMG I on a Bio-Rad RP-318 (C18) column (250 x 4.6 mm) 
using a gradient of water/acetonitrile in 0.1% (v/v) trifluoro- 
acetic acid. The eluted proteins were detected by their UV ab- 
sorption at 214 nm and the peaks quantified on the basis of 
their areas using a Hitachi D-2000 integrator. 
2.5. Amino acid analysis and sequence determination 
The HPLC-purified proteins were hydrolyzed in 6 M HCl for 
24 h and amino acids were analyzed as in [13]. Purified HMG 
proteins or proteolytic fragments of HMG I were sequenced us- 
ing an Applied Biosystems 477A sequencer connected with 120 
A analyzer. HMG I (8 pg) was digested for 2 h at 37°C with 
thermolysin (0.2pg) in 20~1 of 0.1 M ammonium bicarbonate. 
3. RESULTS AND DISCUSSION 
Fig.1. shows the electrophoretic patterns of 
PCA- soluble proteins from confluent untreated 
F9 cells (control cells) and F9 cells, which were in- 
duced to differentiate by treatment with reinoic 
acid and dibutyryl-CAMP for 5 days (induced 
cells). Both control and induced cells contained the 
same major PCA-soluble proteins. However, den- 
sitometric analysis revealed that the levels of HMG 
I and HMG Y were markedly decreased and that of 
histone Hl” increased in the induced cells. It has 
been previously reported [14] that levels of HMG 
1 and HMG 2 decrease in mouse neuroblastoma 
cells induced to differentiate. We observed only a 
relatively small (26 f 4%, n = 3) decrease in the 
content of HMG 2 and no appreciable change in 
HMG 1 in induced F9 cells. The total amount of 
Hl did not change significantly. This is in agree- 
ment with the results of Tan et al. [15]. However, 
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Fig. 1. PCA-soluble proteins from untreated mouse teratocar- 
cinema F9 cells (A) and cells treated with retinoic acid and 
dibutyryl-CAMP (B) analyzed by acetic acid/urea-polyacryl- 
amide gel electrophoresis and densitometry of Coomassie- 
stained gel. Proteins corresponding to 5 x lo6 cells were load- 
ed into both lanes. HMG proteins and ubiquitin from calf 
thymus were run in separate lanes as standards. 
there was a 2.4 + 0.6fold (n = 3) increase in the 
relative proportion of histone Hl” out of total 
histone Hl . 
In order to resolve and purify the low-M, HMG 
proteins more efficiently, the proteins were 
separated using reversed-phase HPLC (fig.2). 
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Fig.2. Comparison of elution profiles of low-M, HMG proteins 
from untreated F9 cells (A) and cells treated with retinoic acid 
and dibutyryl-CAMP (B) chromatographed on a Bio-Rad C4 
column. The protein peaks collected were analyzed by acetic 
acid/urea slab gel electrophoresis (shown as insets): HMG 17 
(l), HMG Y (2), HMG 14 (3) and HMG I (4). 
HMG 17, HMG 14 and HMG I eluted from the 
column as sharp peaks, whereas HMG Y was 
resolved into two peaks. The microheterogeneity 
of HMG Y was also detected in the Spiker gel elec- 
trophoretic system [l l] and was abolished after 
alkaline phosphatase treatment in HMG Y (not 
shown) indicating that the peaks most probably 
represent differentially phosphorylated variants of 
the same protein. HMG Y has been shown to be 
phosphorylated in vivo in Ehrlich ascites, HeLa 
1 
and CHO cells and can be phosphorylated in vitro 
by nuclear kinase II [6,13]. 
Using the HPLC method, it was estimated that 
the induced F9 cells contained 77 f 6% (n = 3) less 
HMG I and 62 + 2% (n = 3) less HMG Y than un- 
treated F9 cells. At the same time, we did not 
observe any significant changes in levels of HMG 
14 and HMG 17. Comparison of the amounts of 
HMG I and HMG Y in log vs plateau phase con- 
trol cells did not reveal any significant changes (not 
shown). 
The amino acid compositions of HMG I and 
HMG Y from F9 cells were found to be very 
similar (both containing less Asx and Ala and more 
Glx than HMG 14 and HMG 17) and comparable 
to those described by Lund et al. [6] for Ehrlich 
ascites cells. The final identification of the low-M, 
HMG proteins (except HMG Y) from F9 cells was 
based on their partial sequencing. The N-terminal 
amino acid sequences of HMG 14 and HMG 17 
were almost identical to those of calf thymus HMG 
proteins [16,17] (fig.3). Automated Edman 
degradation of HMG I and HMG Y did not yield 
amino acids, indicating that the N-terminal amino 
acids of both proteins were blocked. 
To compare the amino acid sequence of HMG I 
from F9 cells with the partial sequence (105 amino 
acids) of HMG I from human placenta [18], HMG 
I from F9 cells was digested with thermolysin and 
the sequences of three HPLC-purified internal 
fragments (ThA, Thn, The) were determined. The 
sequences of these peptides (a total of 50 amino 
acids) differed from that of the human protein on- 
ly to a small extent, indicating that HMG I from 
10 20 
HMG 17 Pro-Lys-Arg-Lys-Ala-Glu-Gly-Asp-Ala-Lys-G~y-Asp-Lys-Thr-Lys-Val-Lys-Asp-Glu-Pro 
HMG 17~~ I__________________________________________________________________________Ala__________________________________ 
1 10 
HMG 14 Pro-Lys-Arg-Lys-Val-Ser( - )Ala-Asp-Gly-Ala-Ala-Lys-Ala-Glu-Pro-Lys-Arg-Arg 
HMG 14CT I__________________________ _ Ser_____Glu____ __________________ Glu_____________________________ 
Fig.3. N-terminal amino acid sequences of HMG 14 and HMG 17 from mouse F9 cells and the corresponding calf thymus (CT) pro- 
teins. Amino acid residues differing between the homologous proteins are indicated. 
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T”A 
Th2HP 
ThB 
Th3HP 
ThC 
Th5HP 
Leu-Ala-Ser-Lys-Gln-Glu-Lys-Asp-Gly-Thr-Glu-Lys-Arg-Gly-GIn-Gly-Arg-Pro-Arg-Lys-Gln 
I_______________________ _________ ______________________________________ _______ ____X__________________________________ 
Leu-Val-Gly-Ser-Gln-Ser-GIn-Lys-Glu-Pro-Ser-Glu-Val-Pro 
I_______________________________________________________________________________ 
Val-Thr-Thr-Ala-Pro-Gly-Arg-Lys-Pro-Arg-Gly-Arg-Pro-Lys-Lys 
I____ ______ Thr ___________ ____________________________________________________l 
Fig.4. Amino acid sequences of the three internal thermolysin fragments of HMG 1 from F9 cells. Amino acid residues which are dif- 
ferent from those of HMG I from human placenta are indicated. (X: unidentified residue). 
F9 cells is highly homologous with HMG I from 
human cells (fig.4). The unidentified residue (X) in 
the human protein was identified as Gln in the 
mouse protein. Furthermore, the N-terminal end 
of the The-peptide from F9 cells (Val-Thr-Thr- 
Ala) differed from that in the corresponding 
human protein (Thr-Thr-Thr-Thr) [ 181. The palin- 
dromic amino acid sequences Lys-Pro-Arg-Gly- 
Arg-Pro-Lys, which may play a role in binding of 
HMG I to A-T-rich sequences in the minor groove 
of DNA [18,19], is also found in mouse HMG I. 
The significant decrease in relative amount of 
HMG I during teratocarcinoma cell differentiation 
is probably related to the disappearance of a 
previously unidentified low-M, HMG protein, 
HMG 9, in F9 cells treated with retinoic acid [ 15 1. 
On the basis of the present results, we suggest hat 
HMG 9 and HMG I are identical. HMG I has been 
demonstrated in proliferating human, monkey, 
mouse and rat cells [6,19,20] but not in transform- 
ed chicken erythrocytes, which had progressed to a 
late stage along the differentiation pathway [20]. 
HMG Y has been found in human, mouse and 
hamster cells [6,13]. The present results suggest 
that HMG I and HMG Y, both phosphoproteins, 
are HMG proteins specific for undifferentiated 
cells. Further binding and cross-linking studies are, 
however, required to elucidate and confirm the in- 
volvement of these proteins in maintaining the un- 
differentiated state of chromatin. 
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